Metachronous colorectal cancer: A competing risks analysis with consideration for a stratified approach to surveillance colonoscopy

Journal of Surgical Oncology

Volumn 109, Issue 5, 2014, Pages 445-450

  Battersby, Nicholas J ^a   Coupland, Alex ^a   Bouliotis, George ^b   Mirza, Nazzia ^a   Williams, J Graham ^a  

^a ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

colorectal cancer; competing risks analysis; metachronous; surveillance colonoscopy

Indexed keywords

AGE; AGED; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; COLONOSCOPY; COLORECTAL CANCER; CONFERENCE PAPER; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYPECTOMY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR LOCALIZATION;

COLORECTAL CANCER; COMPETING RISKS ANALYSIS; METACHRONOUS; SURVEILLANCE COLONOSCOPY;

ACTUARIAL ANALYSIS; ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84897028892     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23504     Document Type: Conference Paper

References (34)

1. Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ, Christensen MA:, Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993; 36: 388-393.
2. Warren S, Gates O:, Multiple primary malignant tumors: A survey of the literature and statistical study. Am J Cancer 1932; 16: 1358-1414.
3. Kaibara N, Koga S, Jinnai D:, Synchronous and metachronous malignancies of the colon and rectum in Japan with special reference to a coexisting early cancer. Cancer 1984; 54: 1870-1874.
4. Heald RJ:, Synchronous and metachronous carcinoma of the colon and rectum. Ann R Coll Surg Engl 1990; 72: 172-174.
5. Finan PJ, Ritchie JK, Hawley PR:, Synchronous and "early" metachronous carcinomas of the colon and rectum. BJS 1987; 74: 945-947.
6. Bülow S, Svendsen LB, Mellemgaard A:, Metachronous colorectal carcinoma. BJS 1990; 77: 502-505.
7. Rennert G, Robinson E, Rennert HS, Neugut AI:, Clinical characteristics of metachronous colorectal tumors. Int J Cancer 1995; 60: 743-747.
8. Park IJ, Yu CS, Kim HC, Jung YH, Han KR, Kim JC:, Metachronous colorectal cancer. Colorectal Dis 2006 8: 323-327.
9. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET, and the National Polyp Study Workgroup: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. NEJM 1993; 329: 1977-1981.
10. Hoff G, Grotmol T, Skovlund E, Bretthauer M:, Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: Randomised controlled trial. BMJ 2009; 338: b1846.
11. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J;, UK Flexible Sigmoidoscopy Trial Investigators: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet 2010; 375: 1624-1633.
12. Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, Eaden JA, Rutter MD, Atkin WP, Saunders BP, Lucassen A, Jenkins P, Fairclough PD, Woodhouse CR;, British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland: Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010; 59: 666-689.
13. Müller AD, Sonnenberg A:, Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995; 123: 904-910.
14. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ:, Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
15. Royston P, Lambert P:, Further development of flexible parametric models for survival analysis. Stata J 2009; 9: 265-290.
16. Royston P, Lambert P:, Flexible parametric survival analysis using Stata: Beyond the Cox model, Texas: Stata Press; 2011. p. 347.
17. Fine J, Gray R:, A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 495-509.
18. Mills J:, What are the chances of surviving to age 100? Demographic analysis [Internet]. UK; 2012. Available from: http://www.ons.gov.uk/ons/rel/ lifetables/historic-and-projected-mortality-data-from-the-uk-life-tables/ 2010-based/rpt-surviving-to-100.html
19. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M:, Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 2009; 373: 811-820.
20. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B:, Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000 356: 93-96.
21. Mulder SA, Kranse R, Damhuis RA, Ouwendijk RJT, Kuipers EJ, Van Leerdam ME:, The incidence and risk factors of metachronous colorectal cancer: An indication for follow-up. Dis Colon Rectum 2012; 55: 522-531.
22. Hollington P, Tiong L, Young G:, Timing and detection of metachronous colorectal cancer. ANZ J Surg 2011; 81: 272-274.
23. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL:, Genetic alterations during colorectal-tumor development. NEJM 1988; 319: 525-532.
24. Morson B:, The polyp-cancer sequence in the large bowel. Proc R Soc Med 1974; 67: 451-457.
25. Lynch HT, Smyrk T, Jass JR:, Hereditary nonpolyposis colorectal cancer and colonic adenomas: Aggressive adenomas ? Semin Surg Oncol 1995; 11: 406-410.
26. Ahlquist DA:, Aggressive polyps in hereditary nonpolyposis colorectal cancer: Targets for screening. Gastroenterology 1995; 108: 1590-1592.
27. Bensen S, Mott LA, Dain B, Rothstein R, Baron J:, The colonoscopic miss rate and true one-year recurrence of colorectal neoplastic polyps. Polyp Prevention Study Group. Am J Gastroenterol 1999; 94: 194-199.
28. Green RJ, Metlay JP, Propert K, Catalano PJ, Macdonald JS, Mayer RJ, Haller DG:, Surveillance for second primary colorectal cancer after adjuvant chemotherapy: An analysis of Intergroup 0089. Ann Intern Med: 2002; 136: 261-269.
29. Viel JF, Studer JM, Ottignon Y, Hirsch JP;, Franche-Comté Polyp Surveillance Study Group: Predictors of colorectal polyp recurrence after the first polypectomy in private practice settings: A cohort study. PLoS ONE 2012; 7: e50990.
30. Fajobi O, Yiu CY, Sen-Gupta SB, Boulos PB:, Metachronous colorectal cancers. BJS 1998; 85: 897-901.
31. Fante R, Roncucci L, Di Gregorio C, Tamassia MG, Losi L, Benatti P, et al.: Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma. Cancer 1996; 77: 2013-2021.
32. Singer JD, Willet JB:, Applied longitudinal data analysis: Modeling change and event occurrence. In:, Singer JD, Willett JB, editors. The cumulative hazard function, 1st edition. USA: Oxford University Press; 2003. Chapter 13.4. ISBN0195152964.
33. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, et al.: Guidelines for colonoscopy surveillance after cancer resection: A consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2006; 130: 1865-1871.
34. Bouvier A-M, Latournerie M, Jooste V, Lepage C, Cottet V, Faivre J:, The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up. Eur J Cancer 2008; 44: 522-527.